NAGE FY 2009 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$389M

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+28.2% YoY

Gross Profit

$2M35.3% margin

Operating Income

-$892,732-15.5% margin

Net Income

-$907,568-15.7% margin

EPS (Diluted)

$-0.09

Cash Flow

Operating Cash Flow

-$396,172

Free Cash Flow

-$580,659

Stock-Based Comp.

$205,858

Balance Sheet

Total Assets

$4M

Total Liabilities

$3M

Stockholders' Equity

$1M

Cash & Equivalents

$471,378

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$5M	+28.2%
Gross Profit	$2M	$1M	+65.8%
Operating Income	-$892,732	-$2M	+56.7%
Net Income	-$907,568	-$2M	+56.9%